SNCA and Parkinson disease: In Parkinson’s disease, a dysregulated network of miRNAs orchestrates the progression of neurodegeneration by targeting genes involved in α-synuclein accumulation, neuroinflammation, mitochondrial dysfunction, and oxidative stress, ultimately leading to the loss of dopaminergic neurons.